Best Hospitals for Gender Reassignment Surgery in Dubai, UAE

The cost of Gender Reassignment Surgery varies significantly based on the specific procedure or combination of procedures chosen, the complexity of the individual case, and the destination. In India, costs at JCI/NABH-accredited centers range from approximately USD 4,500 (standalone procedures such as orchiectomy or chest masculinization/top surgery) to USD 18,000 (complex procedures such as RFFF phalloplasty with urethral lengthening, or combined vaginoplasty with feminizing surgeries). In the UAE (Dubai and Abu Dhabi), the same procedures are priced at approximately USD 10,000 to USD 38,000, reflecting the premium hospital infrastructure, luxury recovery environment, and operating costs in the Gulf region. India therefore offers savings of 40–60% compared to the UAE for comparable surgical expertise and accreditation standards. It is important to note that these figures are estimates; GAF Healthcare provides a detailed, all-inclusive package quote following a case review. Quoted packages typically include surgeon and anesthesiologist fees, operating theater charges, hospital stay, standard post-operative medications, and in-hospital nursing care. They do not typically include international flights, travel insurance, or ancillary procedures added after the initial assessment. Contact GAF Healthcare at gaf.healthcare for a personalized cost breakdown based on your specific surgical plan.

The minimum safe in-country recovery period — the time required before you are medically cleared to board an international flight — depends directly on which procedure(s) you have undergone. As a general guide: Orchiectomy (standalone) or Chest Masculinization (Top Surgery): Fit to fly in approximately 2–3 weeks, once wound healing is confirmed and drains (if used) have been removed. Vulvoplasty (zero-depth vaginoplasty): Approximately 3–4 weeks, once the perineal wound is stable and healing satisfactorily. Penile Inversion Vaginoplasty (MTF): Minimum 4–6 weeks. This timeline is dictated by the need for supervised vaginal dilation coaching, wound healing of the neovagina and vulva, and urethral stability. Flying with vaginal packing still in place is not permitted. Metoidioplasty (with or without urethral lengthening): Approximately 5–6 weeks. Urethral healing must be confirmed and the suprapubic catheter (if placed) removed and urination confirmed before travel. RFFF or ALT Flap Phalloplasty: Minimum 6–8 weeks. This is the most complex reconstruction; the suprapubic catheter typically remains for 4–6 weeks, and voiding cystourethrogram confirmation of urethral integrity is required before catheter removal and travel clearance. Deep vein thrombosis (DVT) risk on long-haul flights is a critical consideration for all post-GRS patients, particularly MTF patients on estrogen therapy. Your GAF Healthcare team will ensure you have appropriate thromboprophylaxis advice (compression stockings, hydration, ambulatory exercises) for the flight, and a fit-to-fly certificate issued by your treating surgeon.

Gender Reassignment Surgery has one of the highest patient-reported satisfaction rates of any elective surgical intervention in reconstructive medicine. Overall success and satisfaction rates, as reported in systematic reviews and long-term prospective cohort studies (including meta-analyses published in the Journal of Sexual Medicine and the American Journal of Psychiatry), are as follows: Patient-reported satisfaction with surgical outcomes: greater than 94% at 12-month follow-up across MTF and FTM procedures. Functional success rates (e.g., adequate neovaginal depth and capacity for MTF vaginoplasty, standing urination and neophallic aesthetics for FTM): 88–93% at high-volume centers following primary procedures. Psychological well-being improvement: Studies consistently report significant and durable reductions in gender dysphoria severity, depression scores, and anxiety scales, with quality-of-life improvements maintained at 5–10 year follow-up. Surgical complication rates requiring major revision: approximately 10–20% for phalloplasty (primarily urethral fistula or stricture requiring minor secondary correction) and 5–15% for vaginoplasty (primarily vaginal stenosis in patients non-compliant with dilation). These complication rates are substantially lower at high-volume subspecialty centers compared to low-volume centers — a key reason why selecting an experienced, accredited surgical team through GAF Healthcare is critical. Regret rates in carefully selected patients meeting WPATH SOC8 criteria are consistently reported below 1–2% in modern long-term studies, underscoring the importance of comprehensive pre-operative psychological evaluation. Success is maximized by choosing a high-volume surgeon at a JCI or NABH/DHA accredited center, strict adherence to post-operative dilation or catheter protocols, and consistent follow-up care — all of which GAF Healthcare coordinates on your behalf.